CDH1-involved Ubiquitination of SIRT5 Promotes the Entry of Colorectal Cancer Cells into Quiescence and Enhances Cell Stemness
- PMID: 39945249
- DOI: 10.2174/0118715206336851241204111721
CDH1-involved Ubiquitination of SIRT5 Promotes the Entry of Colorectal Cancer Cells into Quiescence and Enhances Cell Stemness
Abstract
Background: This study explored whether the cell cycle regulator cadherin 1 (CDH1) impacts colorectal cancer cell cycle and stemness via mediating ubiquitination of sirtuin 5 (SIRT5).
Methods: We first constructed CDH1 overexpression plasmid and small interfering RNA against SIRT5 (siSIRT5) and transfected them into HCT116/HT29 cells, followed by transfection efficiency verification. The effect of CDH1 on Cyclin F/SIRT5/CDH1 protein levels in HCT116/HT29 cells was verified by Western blot. After up-regulation of CDH1, changes in SIRT5 ubiquitination (immunoprecipitation), cell cycle (cell cycle kit), proliferation (5-Bromodeoxyuridine assay), and stemness marker expressions (qRT-PCR) in HCT116/HT29 cells were detected. Rescue assays were performed to examine cell proliferation and stemness marker expressions.
Results: Overexpression of CDH1 decreased Cyclin F expression and increased SIRT5 and CDH1 expressions in HCT116/HT29 cells. Up-regulation of CDH1 suppressed SIRT5 ubiquitination, promoted G0/G1 phase blockage in HCT116/HT29 cells, boosted cell proliferation into quiescence and enhanced cell stemness. siSIRT5 counteracted the regulatory effect of CDH1 overexpression on colorectal cancer cells.
Conclusion: CDH1 promotes the entry of colorectal cancer cells into quiescence and enhances stemness by dampening SIRT5 ubiquitination.
Keywords: Colorectal cancer; cadherin 1; cancer cell cycle and stemness; cyclin F expression.; sirtuin 5; ubiquitination.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Transcriptional activation of SIRT5 by FOXA1 reprograms glycolysis to facilitate the malignant progression of diffuse large B-cell lymphoma.Cell Signal. 2024 Nov;123:111356. doi: 10.1016/j.cellsig.2024.111356. Epub 2024 Aug 22. Cell Signal. 2024. PMID: 39173857
-
TRIM24/ZFX affects the stemness and resistance to 5-FU of colorectal cancer cells.J Chemother. 2025 Jul;37(4):353-364. doi: 10.1080/1120009X.2024.2376422. Epub 2024 Sep 2. J Chemother. 2025. PMID: 39221698
-
Sirtuin 5 inhibits mitochondrial metabolism in liver cancer cells and promotes apoptosis by mediating the desuccinylation of CS.Front Immunol. 2025 Jun 10;16:1560989. doi: 10.3389/fimmu.2025.1560989. eCollection 2025. Front Immunol. 2025. PMID: 40557149 Free PMC article.
-
The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review.Drug Des Devel Ther. 2015 Apr 13;9:2149-57. doi: 10.2147/DDDT.S75429. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25926721 Free PMC article.
-
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer.Eur J Cancer. 2011 Mar;47(4):631-9. doi: 10.1016/j.ejca.2010.10.011. Epub 2010 Nov 22. Eur J Cancer. 2011. PMID: 21106365
References
-
- Jin K; Ren C; Liu Y; Lan H; Wang Z; An update on colorectal cancer microenvironment, epigenetic and immunotherapy. Int Immunopharmacol 2020,89(Pt A),107041 - DOI
-
- Kim B.J.; Hanna M.H.; Colorectal cancer in young adults. J Surg Oncol 2023,127(8),1247-1251 - DOI
-
- McQuade R.M.; Stojanovska V.; Bornstein J.C.; Nurgali K.; Colorectal cancer chemotherapy: The evolution of treatment and new approaches. Curr Med Chem 2017,24(15),1537-1557 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous